Identification of sVSG117 as an Immunodiagnostic Antigen and Evaluation of a Dual-Antigen Lateral Flow Test for the Diagnosis of Human African Trypanosomiasis

PLoS Neglected Tropical Diseases

Volumn 8, Issue 7, 2014, Pages

  Sullivan, Lauren ^a   Fleming, Jennifer ^a,c   Sastry, Lalitha ^a   Mehlert, Angela ^a   Wall, Steven J ^b   Ferguson, Michael A J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b BBI Solutions Alchemy House   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SVSG117 ANTIGEN; UNCLASSIFIED DRUG; VARIANT SURFACE GLYCOPROTEIN; DIAGNOSTIC KIT;

AFRICAN TRYPANOSOMIASIS; ARTICLE; CARD AGGLUTINATION TEST FOR TRYPANOSOMIASIS; CONTROLLED STUDY; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOREACTIVITY; LATERAL FLOW TEST; MAJOR CLINICAL STUDY; POLYACRYLAMIDE GEL ELECTROPHORESIS; SENSITIVITY AND SPECIFICITY; TRYPANOSOMA GAMBIENSE; TRYPANOSOMA RHODESIENSE; COHORT ANALYSIS; DIAGNOSTIC KIT; IMMUNOLOGY; PARASITOLOGY; PROCEDURES; TRYPANOSOMIASIS, AFRICAN;

COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; REAGENT KITS, DIAGNOSTIC; TRYPANOSOMIASIS, AFRICAN; VARIANT SURFACE GLYCOPROTEINS, TRYPANOSOMA;

EID: 84905505202     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002976     Document Type: Article

References (35)

1. Chappuis F, Loutan L, Simarro P, Lejon V, Buscher P, (2005) Options for field diagnosis of human african trypanosomiasis. Clinical microbiology reviews 18: 133-146.
2. Tong J, Valverde O, Mahoudeau C, Yun O, Chappuis F, (2011) Challenges of controlling sleeping sickness in areas of violent conflict: experience in the Democratic Republic of Congo. Conflict and health 5: 7.
3. Van Nieuwenhove S, Betu-Ku-Mesu VK, Diabakana PM, Declercq J, Bilenge CM, (2001) Sleeping sickness resurgence in the DRC: the past decade. Tropical medicine & international health: TM & IH 6: 335-341.
4. Priotto G, Kasparian S, Mutombo W, Ngouama D, Ghorashian S, et al. (2009) Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial. Lancet 374: 56-64.
5. Babokhov P, Sanyaolu AO, Oyibo WA, Fagbenro-Beyioku AF, Iriemenam NC, (2013) A current analysis of chemotherapy strategies for the treatment of human African trypanosomiasis. Pathogens and global health 107: 242-252.
6. Lutje V, Seixas J, Kennedy A, (2013) Chemotherapy for second-stage human African trypanosomiasis. The Cochrane database of systematic reviews 6: CD006201.
7. Torreele E, Bourdin Trunz B, Tweats D, Kaiser M, Brun R, et al. (2010) Fexinidazole-a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness. PLoS neglected tropical diseases 4: e923.
8. Nare B, Wring S, Bacchi C, Beaudet B, Bowling T, et al. (2010) Discovery of novel orally bioavailable oxaborole 6-carboxamides that demonstrate cure in a murine model of late-stage central nervous system african trypanosomiasis. Antimicrobial agents and chemotherapy 54: 4379-4388.
9. Odiit M, Shaw A, Welburn SC, Fevre EM, Coleman PG, et al. (2004) Assessing the patterns of health-seeking behaviour and awareness among sleeping-sickness patients in eastern Uganda. Annals of tropical medicine and parasitology 98: 339-348.
10. Deborggraeve S, Buscher P, (2010) Molecular diagnostics for sleeping sickness: what is the benefit for the patient? The Lancet infectious diseases 10: 433-439.
11. Jamonneau V, Bucheton B, Kabore J, Ilboudo H, Camara O, et al. (2010) Revisiting the immune trypanolysis test to optimise epidemiological surveillance and control of sleeping sickness in West Africa. PLoS neglected tropical diseases 4: e917.
12. Magnus E, Vervoort T, Van Meirvenne N, (1978) A card-agglutination test with stained trypanosomes (C.A.T.T.) for the serological diagnosis of T. B. gambiense trypanosomiasis. Annales de la Societe belge de medecine tropicale 58: 169-176.
13. Jamonneau V, Truc P, Garcia A, Magnus E, Buscher P, (2000) Preliminary evaluation of LATEX/T. b. gambiense and alternative versions of CATT/T. b. gambiense for the serodiagnosis of human african trypanosomiasis of a population at risk in Cote d'Ivoire: considerations for mass-screening. Acta tropica 76: 175-183.
14. Chappuis F, Stivanello E, Adams K, Kidane S, Pittet A, et al. (2004) Card agglutination test for trypanosomiasis (CATT) end-dilution titer and cerebrospinal fluid cell count as predictors of human African Trypanosomiasis (Trypanosoma brucei gambiense) among serologically suspected individuals in southern Sudan. The American journal of tropical medicine and hygiene 71: 313-317.
15. Hasker E, Mitashi P, Baelmans R, Lutumba P, Jacquet D, et al. (2010) A new format of the CATT test for the detection of human African Trypanosomiasis, designed for use in peripheral health facilities. Tropical medicine & international health: TM & IH 15: 263-267.
16. Truc P, Lejon V, Magnus E, Jamonneau V, Nangouma A, et al. (2002) Evaluation of the micro-CATT, CATT/Trypanosoma brucei gambiense, and LATEX/T b gambiense methods for serodiagnosis and surveillance of human African trypanosomiasis in West and Central Africa. Bulletin of the World Health Organization 80: 882-886.
17. Penchenier L, Grebaut P, Njokou F, Eboo Eyenga V, Buscher P, (2003) Evaluation of LATEX/T.b.gambiense for mass screening of Trypanosoma brucei gambiense sleeping sickness in Central Africa. Acta tropica 85: 31-37.
18. Brun R, Blum J, Chappuis F, Burri C, (2010) Human African trypanosomiasis. Lancet 375: 148-159.
19. Radwanska M, (2010) Emerging trends in the diagnosis of human African Trypanosomiasis. Parasitology 137: 1977-1986.
20. Wastling SL, Welburn SC, (2011) Diagnosis of human sleeping sickness: sense and sensitivity. Trends in parasitology 27: 394-402.
21. Robays J, Bilengue MM, Van der Stuyft P, Boelaert M, (2004) The effectiveness of active population screening and treatment for sleeping sickness control in the Democratic Republic of Congo. Tropical medicine & international health: TM & IH 9: 542-550.
22. Dukes P, Gibson WC, Gashumba JK, Hudson KM, Bromidge TJ, et al. (1992) Absence of the LiTat 1.3 (CATT antigen) gene in Trypanosoma brucei gambiense stocks from Cameroon. Acta tropica 51: 123-134.
23. Fevre EM, Picozzi K, Fyfe J, Waiswa C, Odiit M, et al. (2005) A burgeoning epidemic of sleeping sickness in Uganda. Lancet 366: 745-747.
24. Posthuma-Trumpie GA, Korf J, van Amerongen A, (2009) Lateral flow (immuno)assay: its strengths, weaknesses, opportunities and threats. A literature survey. Analytical and bioanalytical chemistry 393: 569-582.
25. Buscher P, Gilleman Q, Lejon V, (2013) Rapid diagnostic test for sleeping sickness. The New England journal of medicine 368: 1069-1070.
26. Sullivan L, Wall SJ, Carrington M, Ferguson MA, (2013) Proteomic selection of immunodiagnostic antigens for human African trypanosomiasis and generation of a prototype lateral flow immunodiagnostic device. PLoS neglected tropical diseases 7: e2087.
27. Franco JR, Simarro PP, Diarra A, Ruiz-Postigo JA, Jannin JG, (2012) The Human African trypanosomiasis specimen biobank: a necessary tool to support research of new diagnostics. PLoS neglected tropical diseases 6: e1571.
28. Cross GA, (1984) Release and purification of Trypanosoma brucei variant surface glycoprotein. Journal of cellular biochemistry 24: 79-90.
29. Mehlert A, Bond CS, Ferguson MA, (2002) The glycoforms of a Trypanosoma brucei variant surface glycoprotein and molecular modeling of a glycosylated surface coat. Glycobiology 12: 607-612.
30. Zamze SE, Ferguson MA, Collins R, Dwek RA, Rademacher TW, (1988) Characterization of the cross-reacting determinant (CRD) of the glycosyl-phosphatidylinositol membrane anchor of Trypanosoma brucei variant surface glycoprotein. European journal of biochemistry/FEBS 176: 527-534.
31. Pays E, Dekerck P, Van Assel S, Babiker EA, Le Ray D, et al. (1983) Comparative analysis of a Trypanosoma brucei gambiense antigen gene family and its potential use in epidemiology of sleeping sickness. Molecular and biochemical parasitology 7: 63-74.
32. Bromidge T, Gibson W, Hudson K, Dukes P, (1993) Identification of Trypanosoma brucei gambiense by PCR amplification of variant surface glycoprotein genes. Acta tropica 53: 107-119.
33. Frasch AC, Borst P, Van den Burg J, (1982) Rapid evolution of genes coding for variant surface glycoproteins in trypanosomes. Gene 17: 197-211.
34. Picozzi K, Fevre EM, Odiit M, Carrington M, Eisler MC, et al. (2005) Sleeping sickness in Uganda: a thin line between two fatal diseases. BMJ 331: 1238-1241.
35. Njiru ZK, Mikosza AS, Matovu E, Enyaru JC, Ouma JO, et al. (2008) African trypanosomiasis: sensitive and rapid detection of the sub-genus Trypanozoon by loop-mediated isothermal amplification (LAMP) of parasite DNA. International journal for parasitology 38: 589-599.